Notice of Intent to Publish a Funding Opportunity Announcement for Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Notice Number:
NOT-HS-24-011

Key Dates

Release Date:
April 08, 2024
Estimated Publication Date of Notice of Funding Opportunity :

July 19, 2024

First Estimated Application Due Date:

October 16, 2024

Earliest Estimated Award Date:

Summer 2025

Earliest Estimated Start Date:

Summer 2025

Related Announcements
  • February 9, 2021 - Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional). See NOFO PA-21-164.  
Issued by

AGENCY FOR HEALTHCARE RESEARCH & QUALITY (AHRQ)

Purpose

The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. 

AHRQ intends to publish a Notice of Funding Opportunity (NOFO) to renew PA-21-164: Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional).  

This NOFO will invite applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This NOFO will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. The NOFO will have three focus research areas: 

Use advanced analytics to improve quality at the point of care. 

Use innovative, patient-centered, clinician and patient facing digital healthcare technologies to improve patient experiences and healthcare services delivery at the point of care. 

Use evidence-based knowledge and patient-data to augment support for clinical decision-making at the point of care. 

Transition to the R33 phase is not guaranteed for all grants awarded under this NOFO. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds. 

This Notice encourages investigators with appropriate expertise and capabilities to begin to consider applying for the upcoming NOFO. AHRQ intends to publish the NOFO in July 2024.   

Note:  Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) NOFO PA-21-164 expires on July 18, 2024.  

Funding Information

Estimated Total Funding

TBD

Expected Number of Awards
TBD
Estimated Award Ceiling

TBD

Primary Assistance Listing Number(s)

TBD

Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Regional Organization

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:

Stephanie R. Pitts, Ph.D. 
Health Scientist Administrator, Digital Healthcare Research Division 
Center for Evidence and Practice Improvement 
Agency for Healthcare Research and Quality 
Email: [email protected]